Tag Archives: MCI

Mild Cognitive Impairment: Diagnosis and Management (JAMA)

Posted on December 18, 2014 by Dementia and Elderly Care News

Summary Mild cognitive impairment (MCI), defined as the “pre-dementia stage on the continuum of cognitive decline, characterized by objective impairment in cognition that is not severe enough to require help with usual activities of daily living”, tends to occur in … Continue reading →

Posted in Community Care, For Nurses and Therapists (mostly), For Researchers (mostly), International, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, Systematic Reviews, Universal Interest | Tagged Aerobic Exercise, Cognitive Activity, Cognitive Decline, Department of Internal Medicine, Department of Neurology and Stroke Program: University of Michigan, Institute for Healthcare Policy and Innovation: University of Michigan, Institute for Social Research: University of Michigan, Institute of Gerontology: University of Michigan, JAMA, Late-Life Cognitive Decline, MCI, MCI: Mild Cognitive Impairment, Mental Wellbeing, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Mild Cognitive Impairment More Prevalent in Men, National Institute on Aging (NIA), Physical Activity, Physical Activity as a Protective Factor for Cognitive Decline and Dementia, Pre-Dementia (MCI), Primary Care, Progression of Mild Cognitive Impairment to Dementia, Rates of Conversion From Mild Cognitive Impairment to Dementia, Risk and Protective Factors for Cognitive Decline and Dementia, Social Engagement, Social Inclusion, United States, University of Michigan, USA, Veterans Affairs Center for Clinical Management Research: Michigan | Leave a comment

Centrally Acting ACE Inhibitors Reduce Rate of Cognitive Decline in Dementia? (BMJ Open)

Posted on July 28, 2013 by Dementia and Elderly Care News

Summary It has been found that taking angiotensin-converting enzyme (ACE) inhibitors, a class of drugs which help to reduce blood pressure by relaxing the walls of blood vessels, may help to slow mental decline in people diagnosed with dementia. The … Continue reading →

Posted in For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Hypertension, In the News, International, Management of Condition, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, Universal Interest | Tagged ACE Inhibitors, Angiotensin Receptor Blockers Associated with Decreased Incidence and Progression of Dementia, Antihypertensive Medications, Atlantic Philanthropies, Behind the Headlines, Blood Pressure, BMJ Open, Canada, Canadian Institutes of Health Research, Cardiovascular Health Study, Centrally Acting ACE Inhibitors, Centrally Acting ACE inhibitors (CACE-Is), Centre for Gerontology and Rehabilitation: University College Cork, Cognitive Decline, Cognitive Decline in Dementia, Cognitive Impairment, Health Services Executive Ireland, Ireland, Irish Hospice Foundation, MCI, MCI: Mild Cognitive Impairment, McMaster University: Canada, Mercy University Hospital, Mild Cognitive Impairment, NewCACE-I, ONTARGET and TRANSCEND Trials, Perindopril Protection Against Recurrent Stroke Study (PROGRESS), Quick Mild Cognitive Impairment (Qmci) Screen, St Finbarrs' Hospital: Cork City, Standardised Mini-Mental State Examination (SMMSE), Study on Cognition and Prognosis in the Elderly (SCOPE), Systolic Hypertension in Europe (Syst-Eur) Study, University College Cork | Leave a comment

Two Sides of the Dementia Case-Finding Debate (BMJ)

Posted on June 21, 2013 by Dementia and Elderly Care News

Summary The UK government is introducing incentives for general practitioners to check for dementia in patients aged 75 and older, with the intention that timely diagnosis facilitates earlier support for patients with dementia. Critics of this policy allege that this … Continue reading →

Posted in Acute Hospitals, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Models of Dementia Care, National, NHS, Patient Care Pathway, Quick Insights, Standards, UK, Universal Interest | Tagged BMJ, British Medical Journal (BMJ), Case Finding for Patients with Dementia, Commissioning for Quality and Innovation (CQUIN) Indicators, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Commissioning for Quality and Innovation (CQUIN), Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Screening, Ethical Issues of Dementia Care, Ethics and Decision-Making, General Practice, GPs, Head to Head Debates, Incident Dementia, Mandate to the NHS Commissioning Board, MCI, MCI: Mild Cognitive Impairment, Mental Health Care, National Dementia CQUIN, National Screening Committee, NHS Mandate, Prime Minister's Challenge on Dementia, Screening, Screening for Dementia, Timely Diagnosis, UK National Screening Committee | Leave a comment

Alzheimer’s Disease-Related Gray Matter Atrophy Prevention Using B-Vitamin Treatment (NHS Choices / PNAS)

Posted on June 3, 2013 by Dementia and Elderly Care News

Summary Researchers explored the prevention of brain atrophy in areas related to cognitive decline and Alzheimer’s disease (AD) by lowering elevated plasma homocysteine using B vitamins. An earlier study on people with increased dementia risk had indicated that high-dose B-vitamin … Continue reading →

Posted in For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Nutrition, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Alzheimer's Disease, Atrophy and Cognition, B vitamins (Folate B6 and B12), B-Vitamin Supplementation, B-Vitamin Treatments, Behind the Headlines, Brain Atrophy, Critical Appraisals, Diet and Alzheimer's Brain Changes, Dietary Choices, Folic Acid, Functional Magnetic Resonance Imaging of the Brain (FMRIB) Centre: University of Oxford, Gray Matter Atrophy, Homocysteine, John Radcliffe Hospital: Oxford, Magnetic Resonance Imaging (MRI), MCI, Medial Temporal Lobe, Mild Cognitive Impairment (MCI), MRI, MRI Brain Imaging, MRI Scans, Neuropsychological Tests, Nuffield Department of Clinical Neurosciences: University of Oxford, Plasma Homocysteine, PNAS, Proceedings of the National Academy of Sciences of the United States of America (PNAS), Regional Brain Atrophy, University of Oxford, Vitamin B Slows the Progression of Alzheimer’s Disease, Vitamin B12, Vitamin B6 | Leave a comment

Systematic Review of Treatments to Prevent Cognitive Decline (CMAJ: Journal of the Canadian Medical Association)

Posted on April 27, 2013 by Dementia and Elderly Care News

Summary This systematic review examined the best 32 randomised controlled trials (RCTs) investigating treatments for cognitive decline, including drug treatments, hormone therapies, nutritional supplements, physical activity and cognitive exercises. The authors looked comprehensively at pharmacological treatments and non-pharmacological treatments in healthy … Continue reading →

Posted in For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, Systematic Reviews | Tagged Behind the Headlines, Brain Training, Canada, Canadian Medical Association Journal, Cholinesterase Inhibitors, CMAJ: Canadian Medical Association Journal, Cognitive Activity and Cognitive Decline, Cognitive Decline, Cognitive Decline Studies, Cognitive Exercises, Cognitive Impairment, Cognitive Stimulation Therapy, Cognitive Training, Cognitive Training Exercises, DHEA (Synthetic Version of Hormone Produced by Adrenal Glands), Divisions of Geriatric Medicine and General Internal Medicine: University of Toronto, Estrogens, Exercise, Exercise for Cognitive Impairment, Exercise Regimens, Fatty Acids, Fish Oil, Fish-Oil Supplements, Ginkgo Biloba Extract, Hormonal Therapies, Hormone Therapy (HT), Journal de l'Association Medicale Canadienne, MCI, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Moderate Exercise, NMDA (N-Methyl-D-Aspartate), Nutritional Supplements, Oestrogens, Omega-3 Fatty Acids, Omega-3 PUFA Supplementation (Dietary), Oral Nutritional Supplements, Oral Nutritional Supplements (ONS), Polyunsaturated Fatty Acids (PUFA), Prevention, Prophylaxis, PUFA: Polyunsaturated Fatty Acids, Sudoku, Testosterone, University of Toronto, Vitamin Pills | Leave a comment

Exploring the Potential of Deep Brain Stimulation (TED Talk by Neurosurgeon Andres Lozano)

Posted on April 25, 2013 by Dementia and Elderly Care News

Summary Neurosurgeon Andres Lozano discusses recent developments in the potential uses of deep brain stimulation (DBS) for the alleviation of symptoms across many different neurological / neuropsychological conditions, including Parkinson’s Disease, dystonia, depression and other mental illnesses, and possibly even … Continue reading →

Posted in Depression, International, Mental Health, Non-Pharmacological Treatments, Parkinson's Disease, Quick Insights, Universal Interest | Tagged Alzheimer's Disease, Andres Lozano (Neurosurgeon), Brain Imaging, Deep Brain Stimulation (DBS), Deep Brain Stimulation for the Treatment of Alzheimer Disease, Deep Brain Stimulation for the Treatment of Dementia, Dystonia, Fornix, Lewy Body Society, Magnetic Resonance Imaging (MRI), MCI, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), MRI, MRI Scans, Neurodegeneration, Neurodegenerative Diseases, Neuroimaging, Neuroimaging of Dementia, Neurological Disease, Neurology, Neuropsychology, Nucleus Basalis of Meynert, Pre-Dementia (MCI), TED Conference, TED Talks, TEDTalks, TEDxCaltech, Toronto, Toronto Western Hospital, Treatment of Alzheimer's Disease, University of Toronto, YouTube | Leave a comment

Inappropriate Long-Term Use of Antipsychotic Drugs for People with Dementia in Specialised Care Units (BMC Pharmacology and Toxicology)

Posted on February 12, 2013 by Dementia and Elderly Care News

Summary This study investigated use of antipsychotic drug therapy for the treatment of behavioural and psychological symptoms of dementia (BPSD) among 344 people with dementia living in 40 specialised care units in Sweden. 132 persons (38%) in the study population … Continue reading →

Posted in Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Mental Health, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Aggression, Aggressive Behaviour, Behavioral and Psychological Symptoms of Dementia (BPSD), BMC Pharmacology and Toxicology, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, County Council of Västerbotten, Indications for Antipsychotic Treatment, Lions Research Foundation for Age-Related Diseases, Long-Term Treatment, MCI, Mental Health Care, Mild Cognitive Impairment (MCI), Multi-Dimensional Dementia Assessment Scale (MDDAS), Passive Behaviour, Passivity, Prescribing Patterns, Psychological Symptoms of Dementia (BPSD), Specialised Care Units, Sweden, Swedish Dementia Association, Umeå University (Sweden) | Leave a comment

Tag Archives: MCI

Centrally Acting ACE Inhibitors Reduce Rate of Cognitive Decline in Dementia? (BMJ Open)

Alzheimer’s Disease-Related Gray Matter Atrophy Prevention Using B-Vitamin Treatment (NHS Choices / PNAS)

Systematic Review of Treatments to Prevent Cognitive Decline (CMAJ: Journal of the Canadian Medical Association)

Exploring the Potential of Deep Brain Stimulation (TED Talk by Neurosurgeon Andres Lozano)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites